Launch of a phase 3 clinical trial in the treatment of Alzheimer’s disease with masitinib AB Science, 20 May 2013 Accessed on 21 May 2013 from http://www.ab-science.com/file_bdd/1369064860_absciencepressreleasephase3alzenfinal.pdf. CommentRecommendBookmarkWatch